Health

Alkermes’ New Therapy Shows Promise for ADHD Treatment

Updated 2026-09-21 11:10 UTC 1 source Positive

Alkermes' orexin agonist therapy showed potential to treat people with ADHD in an early-stage trial. The drugmaker is optimistic about the treatment's future prospects.

Coverage timeline — 1 article

STAT News

STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.

2026-09-21 11:00 UTC